Lan Ge Selected Research

NOX-B11-2

3/2006

Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lan Ge Research Topics

Disease

6	Neoplasms (Cancer) 12/2021 - 09/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2021
3	Inflammation (Inflammations) 11/2019 - 07/2007
3	Wounds and Injuries (Trauma) 01/2018 - 07/2012
3	Fibrosis (Cirrhosis) 08/2015 - 07/2012
3	Infarction (Infarctions) 03/2015 - 01/2013
2	Breast Neoplasms (Breast Cancer) 12/2019 - 12/2004
2	Reperfusion Injury 03/2015 - 01/2013
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2015 - 01/2013
2	Obesity 06/2013 - 03/2006
2	Body Weight (Weight, Body) 08/2008 - 03/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Heart Failure 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Rosacea (Acne Rosacea) 01/2021
1	Bacterial Vaginosis 01/2021
1	Pulmonary Embolism 11/2019
1	Thrombosis (Thrombus) 11/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Papillary Thyroid Cancer 01/2019
1	Neurobehavioral Manifestations 01/2019
1	Hypertension (High Blood Pressure) 08/2015
1	Liver Neoplasms (Liver Cancer) 02/2015
1	Rheumatoid Arthritis 01/2015
1	Experimental Arthritis 01/2015
1	Hypertrophy 02/2014
1	Iron Deficiencies 09/2013
1	Anemia 09/2013
1	Coronary Disease (Coronary Heart Disease) 06/2013
1	Ventricular Remodeling 01/2013
1	Disseminated Intravascular Coagulation 08/2012
1	Venous Thromboembolism 08/2012
1	Blood Coagulation Disorders 08/2012
1	Infections 03/2012

Drug/Important Bio-Agent (IBA)

3	Peptide Hydrolases (Proteases)FDA Link 07/2007 - 09/2003
3	beta-ArrestinsIBA 07/2007 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2006
2	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2013
2	Liposomes (Liposome)IBA 09/2013 - 01/2013
1	LuciferasesIBA 01/2022
1	Circular RNAIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	EpitopesIBA 12/2021
1	Histones (Histone)IBA 01/2021
1	zhenwu decoctionIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021
1	EnzymesIBA 01/2021
1	IsoenzymesIBA 01/2021
1	LigandsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	MitogensIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	Long Noncoding RNAIBA 12/2019
1	NF-kappa B (NF-kB)IBA 12/2019
1	chromogranin A (344-364)IBA 11/2019
1	Thrombin FDA Link 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	propylene diquat (PDQ(+))IBA 01/2019
1	human MIRN1270 microRNAIBA 01/2019
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Poloxamer (Poloxamer 407)IBA 01/2016
1	Angiotensin IIIBA 08/2015
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2015
1	Deoxyribonucleases (DNase)FDA Link 03/2015
1	salicylhydroxamic acid (SHAM)IBA 03/2015
1	Deoxyribonuclease I (Nickase)IBA 03/2015
1	AflatoxinsIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Collagen Type II (Type II Collagen)IBA 01/2015
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2015
1	SolutionsIBA 01/2015
1	N- (3- iodo- 4- azidophenylpropionamido)- S- (2- thiopyridyl)cysteineIBA 01/2015
1	Wheat Germ AgglutininsIBA 02/2014
1	CollagenIBA 02/2014
1	IronIBA 09/2013
1	Clopidogrel (Plavix)FDA Link 06/2013
1	Cytochrome P-450 CYP2C19IBA 06/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2013
1	Proton Pump InhibitorsIBA 06/2013
1	Voltage-Gated Sodium ChannelsIBA 01/2013
1	Biological ProductsIBA 08/2012
1	fibrin fragment D (D-dimer)IBA 08/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2012
1	Monoclonal AntibodiesIBA 03/2012
1	Triglycerides (Triacylglycerol)IBA 08/2008

Therapy/Procedure

2	Therapeutics 12/2021 - 03/2006
1	Aftercare (After-Treatment) 01/2021
1	Transplantation 01/2019
1	Intradermal Injections 01/2018
1	Intramuscular Injections 01/2015
1	Intravenous Injections 01/2015
1	Microspheres (Microsphere) 01/2015